Year: 2025
Type: article
Abstract: “A successful conjugate must effectively deliver oligonucleotides while maintaining safety, stability, and manufacturability.” On August 20, 2025, Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, spoke to Sritama Bose, Associate Director of Chemistry, Orfonyx Bio, about oligonucleotide bioconjugation strategies, delivery challenges, and emerging approaches for tissue-specific targeting. This viewpoint is based on that conversation.
Source: Bioconjugation Insights
Author: Sritama Bose
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4417330371
FWCI:
Cites:
Cited by:
Related to: